How much revenue did Profound Medical generate this year?
Profound Medical has achieved a revenue of 11.36 M USD this year.
Profound Medical Revenue 2024
Profound Medical Revenue
11.36 M USD
Ticker
PRN.TO
ISIN
CA74319B5027
In 2024, Profound Medical's sales reached 11.36 M USD, a 57.79% difference from the 7.2 M USD sales recorded in the previous year.
The Profound Medical Revenue history
| YEAR | REVENUE (undefined USD) | GROSS MARGIN (%) |
|---|---|---|
| 2029e | 136.6 | 3,21 |
| 2028e | 106.72 | 4,11 |
| 2027e | 99.65 | 4,40 |
| 2026e | 54 | 8,12 |
| 2025e | 33.52 | 13,07 |
| 2024e | 11.36 | 38,58 |
| 2023 | 7.2 | 60,87 |
| 2022 | 6.68 | 45,22 |
| 2021 | 6.87 | 42,95 |
| 2020 | 7.3 | 47,56 |
| 2019 | 4.17 | 57,26 |
| 2018 | 2.01 | 31,65 |
| 2017 | 3.78 | 38,18 |
| 2016 | - | - |
| 2015 | - | - |
| 2014 | - | - |
Profound Medical Revenue, EBIT, Net Income CA74319B5027 ·
3 years
5 years
10 years
25 Years
Max
Revenue
EBIT
Net Income
Details
Revenue, EBIT and Profit
ⓘUnderstanding Revenue, EBIT, and Income
Gain insights into Profound Medical, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Profound Medical from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Profound Medical’s net earnings, an ultimate measure of its financial health and profitability.
Yearly Analysis and Comparisons
Observe the yearly bars to understand the annual performance and growth of Profound Medical. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.
Utilizing Expectations for Investment
The expected values for the forthcoming years offer investors a glimpse into Profound Medical’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.
Investment Insights
Leveraging the comparison between Revenue and EBIT helps in assessing Profound Medical’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Profound Medical’s growth potential.
Profound Medical Revenue, EBIT and net profit per share
| Date | Profound Medical Revenue | Profound Medical EBIT | Profound Medical Net Income |
|---|---|---|---|
| 2029e | 136.6 M undefined | 0 undefined | 77.85 M undefined |
| 2028e | 106.72 M undefined | -10.22 M undefined | -2.47 M undefined |
| 2027e | 99.65 M undefined | 40.9 M undefined | 38.27 M undefined |
| 2026e | 54 M undefined | -9.1 M undefined | -6.42 M undefined |
| 2025e | 33.52 M undefined | -22.57 M undefined | -21.96 M undefined |
| 2024e | 11.36 M undefined | -29.44 M undefined | -28.29 M undefined |
| 2023 | 7.2 M undefined | -28.62 M undefined | -28.57 M undefined |
| 2022 | 6.68 M undefined | -29.6 M undefined | -28.67 M undefined |
| 2021 | 6.87 M undefined | -30.29 M undefined | -30.7 M undefined |
| 2020 | 7.3 M undefined | -18.86 M undefined | -21.62 M undefined |
| 2019 | 4.17 M undefined | -14.9 M undefined | -15.22 M undefined |
| 2018 | 2.01 M undefined | -15.58 M undefined | -16.02 M undefined |
| 2017 | 3.78 M undefined | -13.58 M undefined | -14.51 M undefined |
| 2016 | 0 undefined | -11.81 M undefined | -12.32 M undefined |
| 2015 | 0 undefined | -8.78 M undefined | -12.81 M undefined |
| 2014 | 0 undefined | -3.93 M undefined | -7.43 M undefined |
| Revenue | EBIT | Net Income | |
|---|---|---|---|
| 2014 | 0 USD | -3.93 M USD | -7.43 M USD |
| 2015 | 0 USD | -8.78 M USD | -12.81 M USD |
| 2016 | 0 USD | -11.81 M USD | -12.32 M USD |
| 2017 | 3.78 M USD | -13.58 M USD | -14.51 M USD |
| 2018 | 2.01 M USD | -15.58 M USD | -16.02 M USD |
| 2019 | 4.17 M USD | -14.9 M USD | -15.22 M USD |
| 2020 | 7.3 M USD | -18.86 M USD | -21.62 M USD |
| 2021 | 6.87 M USD | -30.29 M USD | -30.7 M USD |
| 2022 | 6.68 M USD | -29.6 M USD | -28.67 M USD |
| 2023 | 7.2 M USD | -28.62 M USD | -28.57 M USD |
| 2024e | 11.36 M USD | -29.44 M USD | -28.29 M USD |
| 2025e | 33.52 M USD | -22.57 M USD | -21.96 M USD |
| 2026e | 54 M USD | -9.1 M USD | -6.42 M USD |
| 2027e | 99.65 M USD | 40.9 M USD | 38.27 M USD |
| 2028e | 106.72 M USD | -10.22 M USD | -2.47 M USD |
| 2029e | 136.6 M USD | 0 USD | 77.85 M USD |
Profound Medical stock margins CA74319B5027 ·
The Profound Medical margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Profound Medical. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Profound Medical.
3 years
5 years
10 years
25 Years
Max
Gross margin
EBIT margin
Profit margin
Details
Margin
ⓘUnderstanding Gross Margin
The gross margin, expressed as a percentage, delineates the gross profit made from the Profound Medical's sales revenue. A higher gross margin percentage indicates that the Profound Medical retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.
EBIT Margin Analysis
EBIT margin represents the Profound Medical's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.
Revenue Margin Insights
The revenue margin demonstrates the Profound Medical's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Profound Medical's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.
Interpreting Expectations
The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Profound Medical. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.
Comparative Analysis
Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Profound Medical's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.
Profound Medical Margin History
| Profound Medical Gross margin | Profound Medical Profit margin | Profound Medical EBIT margin | Profound Medical Profit margin |
|---|---|---|---|
| 2029e | 60.87 % | 0 % | 56.99 % |
| 2028e | 60.87 % | -9.58 % | -2.31 % |
| 2027e | 60.87 % | 41.04 % | 38.41 % |
| 2026e | 60.87 % | -16.85 % | -11.88 % |
| 2025e | 60.87 % | -67.36 % | -65.52 % |
| 2024e | 60.87 % | -259.13 % | -249.07 % |
| 2023 | 60.87 % | -397.5 % | -396.85 % |
| 2022 | 45.22 % | -443.08 % | -429.11 % |
| 2021 | 42.95 % | -440.72 % | -446.66 % |
| 2020 | 47.56 % | -258.26 % | -296.03 % |
| 2019 | 57.26 % | -357.07 % | -364.69 % |
| 2018 | 31.65 % | -775.85 % | -797.88 % |
| 2017 | 38.18 % | -359.4 % | -383.77 % |
| 2016 | 60.87 % | 0 % | 0 % |
| 2015 | 60.87 % | 0 % | 0 % |
| 2014 | 60.87 % | 0 % | 0 % |
| Gross margin | EBIT margin | Profit margin | |
|---|---|---|---|
| 2014 | 60.87 % | 0 % | 0 % |
| 2015 | 60.87 % | 0 % | 0 % |
| 2016 | 60.87 % | 0 % | 0 % |
| 2017 | 38.18 % | -359.4 % | -383.77 % |
| 2018 | 31.65 % | -775.85 % | -797.88 % |
| 2019 | 57.26 % | -357.07 % | -364.69 % |
| 2020 | 47.56 % | -258.26 % | -296.03 % |
| 2021 | 42.95 % | -440.72 % | -446.66 % |
| 2022 | 45.22 % | -443.08 % | -429.11 % |
| 2023 | 60.87 % | -397.5 % | -396.85 % |
| 2024e | 60.87 % | -259.13 % | -249.07 % |
| 2025e | 60.87 % | -67.36 % | -65.52 % |
| 2026e | 60.87 % | -16.85 % | -11.88 % |
| 2027e | 60.87 % | 41.04 % | 38.41 % |
| 2028e | 60.87 % | -9.58 % | -2.31 % |
| 2029e | 60.87 % | 0 % | 56.99 % |
Profound Medical Aktienanalyse
What does Profound Medical do?
Profound Medical is a Canadian medical technology company specializing in the development and marketing of innovative therapy devices for the treatment of prostate cancer and other diseases. Profound Medical ist eines der beliebtesten Unternehmen auf Eulerpool.com.Revenue Details
Understanding Profound Medical's Sales Figures
The sales figures of Profound Medical originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.
Year-to-Year Comparison
Analyzing Profound Medical’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.
Impact on Investments
Investors often scrutinize Profound Medical's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.
Interpreting Sales Fluctuations
Increases in Profound Medical’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.
Frequently Asked Questions about Profound Medical stock
How much was the turnover of the company Profound Medical compared to the previous year?
The revenue of Profound Medical has increased by 57.79% increased compared to the previous year.
What does revenue mean for investors?
The revenue of a company is an important indicator of its financial performance and attractiveness for investors.
Which factors influence the revenue of Profound Medical?
The revenue of Profound Medical is influenced by various factors, including the demand for its products and services, market conditions, and prices.
How is the revenue of Profound Medical measured?
Revenue is typically measured in units referring to the sale of goods and services provided by the company.
How does an increase in sales affect investments?
An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.
What are the possible risks associated with a declining revenue?
A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.
Why is the sales revenue of Profound Medical so important for investors?
The revenue of Profound Medical is an important indicator of financial performance and attractiveness for investors.
What strategic measures can a company take to increase revenue?
A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.
How much dividend does Profound Medical pay?
Over the past 12 months, Profound Medical paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Profound Medical is expected to pay a dividend of 0 USD.
What is the dividend yield of Profound Medical?
The current dividend yield of Profound Medical is .
When does Profound Medical pay dividends?
Profound Medical pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Profound Medical?
Profound Medical paid dividends every year for the past 0 years.
What is the dividend of Profound Medical?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Profound Medical located?
Profound Medical is assigned to the 'Health' sector.
Wann musste ich die Aktien von Profound Medical kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Profound Medical from 7/29/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 7/29/2024.
When did Profound Medical pay the last dividend?
The last dividend was paid out on 7/29/2024.
What was the dividend of Profound Medical in the year 2023?
In the year 2023, Profound Medical distributed 0 USD as dividends.
In which currency does Profound Medical pay out the dividend?
The dividends of Profound Medical are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Profound Medical
Our stock analysis for Profound Medical Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Profound Medical Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
- Profound Medical Revenue
- Profound Medical Net Income
- Profound Medical P/E
- Profound Medical P/S
- Profound Medical EBIT
- Profound Medical Dividend
- Profound Medical Stocks
- Profound Medical Market capitalization
- Profound Medical Debt
- Profound Medical Liabilities
- Profound Medical Equity
- Profound Medical AAQS
- Profound Medical Employees
- Profound Medical ROE
- Profound Medical ROA
- Profound Medical ROCE
